Clinical practice guideline for the management of lipids in adults with diabetic kidney disease: abbreviated summary of the Joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) Guideline 2024
File(s)
Published version
Author(s)
Type
Journal Article
Abstract
The contribution of chronic kidney disease (CKD) towards the risk of developing cardiovascular disease (CVD) is magnified with co-existing type 1 or type 2 diabetes. Lipids are a modifiable risk factor and good lipid management offers improved outcomes for people with diabetic kidney disease (DKD).
The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.
The primary purpose of this guideline, written by the Association of British Clinical Diabetologists (ABCD) and UK Kidney Association (UKKA) working group, is to provide practical recommendations on lipid management for members of the multidisciplinary team involved in the care of adults with DKD.
Date Issued
2024-07-06
Date Acceptance
2024-07-01
Citation
BMC Nephrology, 2024, 25
ISSN
1471-2369
Publisher
BMC
Journal / Book Title
BMC Nephrology
Volume
25
Issue
1
Copyright Statement
© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
License URL
Identifier
https://www.ncbi.nlm.nih.gov/pubmed/38971750
PII: 10.1186/s12882-024-03664-1
Subjects
ALL-CAUSE
CARDIAC OUTCOMES
CARDIOVASCULAR MORTALITY
Chronic kidney disease
Diabetes
Diabetic kidney disease
EFFICACY
LDL-CHOLESTEROL
Life Sciences & Biomedicine
Lipid management
Lipids
Nephropathy
PCSK9 INHIBITOR EVOLOCUMAB
RENAL-TRANSPLANT RECIPIENTS
RISK
SAFETY
Science & Technology
STATINS
Urology & Nephrology
Publication Status
Published
Coverage Spatial
England
Article Number
216
Date Publish Online
2024-07-06